monday.com Ltd., together with its subsidiaries, develops software applications in the United States, Europe, the Middle East, Africa, the United Kingdom, and internationally.
FAIL · Does not pass the screen
94.05 USD
At the last full screen 2026-09-15
Screened 2026-09-15 · the tape above runs as of 23:00 UTC · two dates, stated on purpose · verdict and workings shown in full · never trimmed
The Label · The Season, Not the Day
This name holds its markup label.
monday.com Ltd. holds its Markup at $94.05. Consolidating, no directional conviction, held for 18 days.
As held on the ledger · 2026-09-15
Phase
Markup
Quantitative state
Consolidating, no directional conviction, held for 18 days
Price at the screen
$94.05
Valuation
39.85 trailing · 14.07 forward price to earnings
Values screen
FAIL· score 70.0
Beta
1.15
The Workings
Five Screens, Shown in Full
Does not pass. Accounts receivable
Test
Figure
Limit
What it means
Status
Business activity
Permissible
Core business clean
Its core business isn't built on prohibited lines: no gambling, alcohol, tobacco, weapons, or interest-based lending.
Pass
Debt load
8.01%
Below 33%
Interest-bearing debt is just 8.0% of its assets, well under the one-third ceiling: it does not run on borrowed money.
Pass
Interest-bearing cash
7.70%
Below 33%
Cash held in interest-bearing accounts and securities is 7.7% of assets, under the one-third limit.
Pass
Receivables
72.80%
Below 49%
Money owed to the company is 72.8% of assets, above the 49% limit.
Fail
Revenue purity
5.28%
Below 5%
5.3% of revenue comes from non-compliant sources, over the 5% line.
Fail
Five checks adapted from AAOIFI screening standards: business activity plus four balance-sheet ratios. All five must pass for ethical clearance. Every figure is arithmetic on public accounts, not judgement.
Fair value range in USD, drawn from the 2026-09-15 screen. The gold marker is the market price at the same screen. A 39.6% margin of safety to the base estimate.
Third-party analyst targets: 23 covering, consensus None. The average target sits +12% from the screen price.
Reading the gap · Both our model and the analysts see meaningful upside from here.
Price History & Projections
Where it has been, where the models see it going. History from market close data; projection points are our fair-value estimates and third-party analyst targets, dated to the 2026-09-15 screen.
Fair value and rating are our own model estimates; the Street's range reflects third-party analyst estimates. Analysis, not advice.
The Business, in Plain Words
Work Software Platform Looks Cheap But We Pass
Teams juggling tasks across continents still rely on clunky spreadsheets and scattered apps to stay aligned. monday.com offers a cloud based work operating system that tries to pull everything into one visual space. Yet the opportunity rating sits at none, so we pass despite the numbers.
Revenue grows at 24 percent with a forward multiple of just 14.6 times and a 9 percent profit margin. Return on equity reaches 13 percent while the ethical screen clears cleanly. Analysts lean buy with a 102 dollar median target against our 121 dollar fair value, but the unknown moat leaves too much uncertainty for any real conviction.
Currency swings from its Israeli base and competition from bigger platforms add real downside. Low margins also leave little room if growth slows. Analysis, not advice.
The risks · The things to watch: its business and earnings are exposed to Israel and to currency swings.
Plain-English interpretation of our own screen data. Analysis, not advice.
Where & How to Trade
MNDY trades on Nasdaq (the company is based in Israel). As a listed security it is accessible through almost any international broker offering its home market. New to this, or investing from abroad? Our guide to accessing global markets covers brokers, currencies and the practical steps.
The Dated Journal · Newest First, Never Edited
Every Entry, As Written
2026-09-05Markup$92.55+17.6%Entry 5
The framework reads markup. Price is trending higher with momentum. The crowd has caught on and buyers are in control. Price has moved up 17.6% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows modest positive risk-adjusted returns. Our composite framework grades it C. Technically it is sitting below its long-term trend line with momentum reading neutral. Over the past year the shares are down 73%. Our forward projection puts the odds of a 10% gain over the next month near 20%. The street (25 analysts) rates it buy, with a mean price target of $114.
2026-08-05Markup$78.69+1.4%Entry 4
The framework reads markup. Price is trending higher with momentum. The crowd has caught on and buyers are in control. Price has moved up 1.4% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows modest positive risk-adjusted returns. Our composite framework grades it C. Technically it is sitting below its long-term trend line with momentum reading neutral. Over the past year the shares are down 73%. Our forward projection puts the odds of a 10% gain over the next month near 20%. The street (25 analysts) rates it buy, with a mean price target of $114.
2026-07-18Markup$77.57+0.0%Entry 3
The framework reads markup. Price is trending higher with momentum. The crowd has caught on and buyers are in control. Price has moved down 0.0% since our last review. Ethical screening: PASS with passing ethical screen. The risk-adjusted return profile shows negative risk-adjusted returns. Our composite framework grades it C. Technically it is sitting below its long-term trend line with momentum reading neutral. Over the past year the shares are down 73%. Our forward projection puts the odds of a 10% gain over the next month near 20%. The street (25 analysts) rates it buy, with a mean price target of $114.
2026-07-03Markup$77.57+0.0%Entry 2
The framework reads markup. Price is trending higher with momentum. The crowd has caught on and buyers are in control. Price has moved down 0.0% since our last review. Ethical screening: PASS with passing ethical screen (70). The risk-adjusted return profile shows negative risk-adjusted returns.
2026-07-02Markup$77.57Entry 1
The framework reads markup. Price is trending higher with momentum. The crowd has caught on and buyers are in control. Ethical screening: PASS with passing ethical screen (70). The risk-adjusted return profile shows negative risk-adjusted returns.
Each entry above was written on its date, before the outcome. A journal you can prune is not a journal.
